Agenus competitors

Agenus's competitors include Lava Therapeutics, Tetherex, Regeneron Pharmaceuticals and Anavex
Add company...
Agenus
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
Lava Therapeutics
Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.
Tetherex
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Anavex
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Founding Date
Founding Date
1994
Founding Date
2016
Founding Date
2014
Founding Date
1988
Founding Date
2006
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Lexington, US HQ
Cambridge, GB
Berkeley, US
New York, US
Locations
's-Hertogenbosch, NL HQ
Locations
Oklahoma City, US HQ
Morrisville, US
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Rensselaer, US
Basking Ridge, US
Locations
New York, US HQ
Employees
Employees
255
Employees
4
Employees
N/A
Employees
6,20015% increase
Employees
10
Valuation ($)
Valuation ($)
291.2 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
34 b
Valuation ($)
182.2 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
3.9 k
Facebook likes
751
Twitter followers
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
12.6 k
Twitter followers
743

Financial

Revenue (est.)
Revenue (est.)
$42.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$4.9b (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
($120.7m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
$895.5m (FY, 2016)
Net income
($13.5m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 18.7m (26 days ago)
Latest funding round
$ 43m (3 months ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 171.1m
Total funding raised
$ 18.7m
Total funding raised
$ 46.2m
Total funding raised
$ 8.9m
Total funding raised
$ 12.6m
For sources of this data, please see the company profileDownload Excel

View company profiles

Lava Therapeutics
HQ
's-Hertogenbosch, NL
Employees
4

Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.

View company
Tetherex
HQ
Oklahoma City, US

Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
6,200↑ 15% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

View company
Anavex
HQ
New York, US
Employees
10

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.

View company